Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Ping An Healthcare and Technology Company ( (HK:1833) ) just unveiled an announcement.
Ping An Healthcare and Technology Company Limited has scheduled a board meeting for 24 March 2026 to review and approve the Group’s annual results for the financial year ended 31 December 2025. The board will also consider the declaration of a final dividend, which could signal the company’s profitability and capital allocation stance to investors.
The notice also reconfirms the current composition of the board, spanning executive, non-executive, and independent non-executive directors, underscoring the company’s existing governance structure. Stakeholders will watch the forthcoming results and dividend decision for indications of operational performance and strategic direction in the competitive healthcare technology space.
The most recent analyst rating on (HK:1833) stock is a Hold with a HK$14.50 price target. To see the full list of analyst forecasts on Ping An Healthcare and Technology Company stock, see the HK:1833 Stock Forecast page.
More about Ping An Healthcare and Technology Company
Ping An Healthcare and Technology Company Limited, listed in Hong Kong, operates in the healthcare technology sector as part of the Ping An Group. The company provides digital healthcare services and related technology solutions through its subsidiaries, focusing on the Chinese market and leveraging technology to improve access to medical and health management services.
YTD Price Performance: -6.46%
Average Trading Volume: 14,467,702
Technical Sentiment Signal: Buy
Current Market Cap: HK$28.47B
For a thorough assessment of 1833 stock, go to TipRanks’ Stock Analysis page.